Latest news
Why InnoCare Pharma (SEHK:9969) Is Up 12.9% After Dual Breakthrough Therapy Wins in Cancer and Autoimmune Disease - And What's Next - simplywall.stsimplywall.st · Mon, 10 Aug 2026 10:52:49 GMTETFs Investing in InnoCare Pharma Ltd. Stocks - TradingViewTradingView · Fri, 07 Aug 2026 11:00:48 GMTInnoCare Pharma (SEHK:9969) Following Breakthrough Therapy News And The Undervalued Narrative - simplywall.stsimplywall.st · Fri, 07 Aug 2026 05:51:49 GMTBreakthrough Psoriasis Data For Oral TYK2 Drug Might Change The Case For Investing In InnoCare Pharma (SEHK:9969) - simplywall.stsimplywall.st · Wed, 29 Jul 2026 11:22:54 GMTChina's Innocare says psoriasis oral drug shows 'consistent treatment effect' in late-stage trial - pharma.economictimes.indiatimes.compharma.economictimes.indiatimes.com · Tue, 28 Jul 2026 07:00:00 GMT